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E-mail address: mtsilva@ibmc.up.ptThe predominant deﬁnition of apoptosis considers that the elimination of the apoptosing cell is by
heterolytic degradation following phagocytosis by an assisting scavenger (efferocytosis). However,
an alternative and largely underestimated outcome of apoptosis is secondary necrosis, an autolytic
process of cell disintegration with release of cell components that occurs when there is no interven-
tion of scavengers and the full apoptotic program is completed. Secondary necrosis is the typical
outcome of apoptosis in unicellular eukaryotes but, importantly, it may also occur in multicellular
animals and has been implicated in the genesis of important human pathologies. Secondary necrosis
is a mode of cell elimination with speciﬁc molecular and morphological features and should be con-
sidered the natural outcome of the complete apoptotic program.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Active cell death processes follow suicidal, genetically regu-
lated, programs that make use of an endogenous molecular
machinery [1]. Presently accepted forms of typical active cell death
include apoptosis, necrosis (or necroptosis [2]), autophagic death
and corniﬁcation [3].
Cell death is always followed by cell elimination by cytolytic
disintegration with loss of cell’s identity. The initial description
of apoptosis [4] considered that the elimination of the apoptotic
cell was by heterolytic degradation following phagocytosis by an
assisting scavenger cell. The term efferocytosis was coined for
the removal and degradation by scavengers of apoptotic corpses
[5]. Several cell types are able to phagocytose apoptotic cells but
the cells of the myeloid phagocyte system [6], mainly macro-
phages, are the prime phagocytes for this task [7]. The heterolytic
degradation of the apoptosing cell in the scavenger phagosome [8]
superimposes on the autonomous proteolytic degradation pro-
gressing in the apoptosing cell as part of the apoptotic program
[9] and results in passive necrosis of the phagocytosed apoptotic
cell (heterophagic necrosis) [8,10,11].
The outcome of apoptosis assisted by an auxiliary scavenger cell
is a result of the expression at the surface of apoptosing cells of
apoptotic cell-associated molecular patterns (ACAMPs) [12] that
phagocytes of the multicellular organism recognize as ‘‘eat-me”
signals [13,14]. The most universal and best characterized ‘‘eat-chemical Societies. Published by Eme” signal is the translocation of phosphatidylserine to the outer
leaﬂet of the lipid bilayer, which occurs very early in the apoptotic
process [15]. Besides the ‘‘eat-me” signals, the interaction between
apoptotic cells and scavenger cells uses bridging molecules [13,14]
and ‘‘ﬁnd-me” signals [16,17], as well as absence of ‘‘don’t eat-me”
signals that prevent the phagocytosis of viable cells [18].
Elimination of the early apoptotic cells by scavenger cells is the
norm in the typical course of physiological apoptosis in multicellu-
lar animals, where it is a mechanism of cell deletion operating in
cell populations and tissues to regulate cell numbers [4]. This view
of apoptosis has become predominant in the literature and is the
only one considered in the recommendations on the use of cell
death-related terminology proposed by the Nomenclature Com-
mittee on Cell Death (NCCD) [3,19].
However, a central issue in the apoptotic process is that, when
scavengers do not operate, the apoptotic process proceeds to an
autolytic necrotic outcome. This autolysis was called secondary
necrosis by Wyllie et al. [20] intending to distinguish this mode
of cell elimination from ‘‘cellular necrosis occurring ab initio”,
which should be called ‘‘primary necrosis” [21] (reviewed in
[22]) (Table 1).
The present review will now discuss results which suggest that
secondary necrosis is the natural outcome of the complete apopto-
tic program at all levels of eukaryotic organization and that effer-
ocytosis interrupts that program before apoptosing cells attain
secondary necrosis. Efferocytosis represents an assisting process
used by multicellular animals as a strategy to avoid the deleterious
consequences associated to the progression of apoptosis to auto-
lytic secondary necrosis.lsevier B.V. All rights reserved.
Table 1
Features of pre-necrotic apoptosis [4,20], secondary necrosis [27,35], and primary
necrosis [22].
Apoptosis
Pre-necrotic apoptosis
Cell rounding and shrinking
Nuclear fragmentation (karyorrhexis)
Intense chromatin condensation (pyknosis)
Oligonucleosomal DNA fragmentation
Near-to-Intact cytoplasmic membrane
Phosphatidylserine externalization
Intact lysosomal membranes
Secondary necrosisa
Karyorrhexis
Pyknosis
Release of activated caspase-3
Cytoplasmic swelling
Lysosomal membrane permeabilization
Cytoplasmic membrane permeabilization
Primary necrosis
No nuclear fragmentation
Moderate chromatin condensation
Cell swelling
Lysosomal membrane permeabilization
Cytoplasmic membrane permeabilization
a Apoptotic and necrotic features are in bold and in italic, respectively.
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2.1. Secondary necrosis in multicellular animals
Besides resulting in cell death, apoptosis leads to cell elimina-
tion. Cell elimination is the opposite of mitosis and, like mitosis,
the apoptotic process of cell elimination should primarily be
viewed as a single cell process. However, the predominant charac-
terization of apoptosis in multicellular animals implies that the
apoptotic mode of cell deletion is a two-cell process as it involves
the doomed cell and the assisting scavenger. To analyze the unfold-
ing of the complete apoptotic process of metazoan cells apoptosis
has to be studied in cells apoptosing without the assistance of
scavengers. One approach is to analyze in vitro the progression
of apoptosis in metazoan cells that have been isolated from the so-
cial context of the organism and subjected to an apoptogenic stim-
ulus as was early done by John F. Kerr’s group. In those studies
using murine lymphocytes [23] or a mammalian lymphoblastic cell
line [24] cultured in vitro, apoptosis was seen to progress until a
terminal disintegration by secondary necrosis. Since then, when-
ever in vitro kinetic studies on the progression of apoptosis in
non-phagocytic metazoan primary cells or cell lines were carried
out, thus using conditions where scavenging by phagocytosis of
apoptotic cells is not interfering, the outcome of full developed
apoptosis was secondary necrosis (see, for example, the studies
with mammalian primary cells [25] or immortalized cell lines
[26,27]). Cultured metazoan cells apoptosing in vitro express
‘‘eat-me” signals [28,29] and, if co-incubated with macrophages,
they are phagocytosed [30,31] mimicking the vivo physiological
apoptosis.
Apoptosis follows an intrinsic, genetically controlled, program
[1]. The molecular dissection of this program shows that apopto-
genic stimuli activate in in vitro cultured metazoan cells a se-
quence of molecular events that, when uninterrupted, proceed to
cell disruption by secondary necrosis [27,32]. In vitro and in vivo,
the full apoptotic program comprises two phases (upper path in
Fig. 1). In the ﬁrst (pre-necrotic) phase the apoptosing cell main-
tains cytoplasmic membrane integrity, and molecular alterations
largely due to activated caspases [33] produce the classical apopto-tic phenotype (Table 1 and Fig. 2B). It is during this phase that the
externalization of ‘‘eat-me” signals occurs. The second is a necrotic
phase (secondary necrosis) with cytoplasmic swelling, rupture
of the plasma membrane and terminal cell disintegration
with release of intracellular components (Fig. 2C) following a se-
quence of molecular events that have been described in detail
[27,29,34,35].
Progression of apoptosis to secondary necrosis can be observed
in vivo in situations where clearance by scavengers does not oper-
ate and the complete apoptotic program fully evolves. (i) This is the
case with some physiological situations where apoptotic cells are
shed into ducts or into territories topologically outside the organ-
ism (like the gut or the airways lumen) or in the lumina of the aci-
ni, where the chances of encountering scavengers are small
[36,37]. (ii) The protein tyrosine kinase Mer is one of the phagocyte
receptors engaged in linking the apoptotic cell to the scavenger
phagocyte [38]. Mer knockout mice have macrophage defects
which result in deﬁcient clearance of apoptotic cells [38,39] and
accumulation of secondary necrotic cells was observed [39]. In Cae-
norhabditis elegans mutation in genes required for phagocytosis of
apoptotic cells results in the progression of many of these cells to
secondary necrosis [40,41]. (iii) Moreover, extensive secondary
necrosis has been described in multicellular animals in situations
of massive apoptosis that surmounts the available scavenging
capacity [42–44], and when this capacity is directly affected by
detrimental effects on scavenger cells [45–48] or by processes that
affect molecules involved in phagocytosis of apoptotic cells by
scavenging cells [39,49].
The above observations support the conclusion that the com-
plete apoptotic process in multicellular animals is genetically con-
trolled by an intrinsic program that includes an autolytic
termination by secondary necrosis, which makes that process
self-sufﬁcient leading to self-elimination when scavengers are
not available. The above observations also show that there is an
obvious and important functional limitation associated with effer-
ocytosis: depending on an assisting scavenger cell, this mechanism
fails if that cell is not available or is defective in which case apop-
tosis will proceed to its completion, leading to the secondary ne-
crotic outcome. Importantly, as in the data above reviewed, this
failure and the consequent occurrence of secondary necrosis
in vivo is typically due to defects in, or lack of, scavengers, that is
to mechanisms independent from the apoptotic program which
is running to completion.
Apoptotic bodies may be formed during the degradation phase
by the fragmentation of apoptosing cells as already described in
the initial report of Kerr and collaborators [4]. Although formation
of apoptotic bodies is frequently considered as the rule during
apoptosis, in some otherwise typical apoptotic processes occurring
in vitro or in vivo apoptotic bodies are not produced or are rare
[9,20], so that the elimination of apoptotic cells frequently affects
non-fragmented cells. Like apoptotic cells, apoptotic bodies are ini-
tially enveloped by a membrane with retained integrity, express
‘‘eat-me” signals, and are phagocytosed by scavengers [4] or under-
go secondary necrosis if not cleared [20].
2.2. Secondary necrosis in unicellular eukaryotes
The proposal of the term apoptosis [4] culminated a series of
studies carried out with metazoan tissues and the disclosing of
essential aspects of the molecular machinery of this mode of cell
elimination, and of its genetic control, again was done using mul-
ticellular animals mainly C. elegans and Drosophila [50,51].
The timeline of our knowledge about the apoptotic mode of cell
elimination explains why the concept of apoptosis was initially
linked to multicellularity and was not envisaged as a single cell
event. Since the ﬁrst description of physiological cell death was
Fig. 1. The two pathways of apoptosis in multicellular animals. Apoptosis in multicellular animals may follow two alternative paths that lead to quite diverse elimination
processes, respectively depending on being affected (CLEARANCE) or not (NO CLEARANCE) by phagocytosis of the apoptosing cell by a scavenger. The two paths share a ﬁrst
common pre-necrotic phase (green arrows) during which the dismantling of the doomed cell is initiated by autonomous degradation but with conserved cytoplasmic
membrane integrity, and both paths terminate by cytolysis. In the absence of clearance, the pre-necrotic phase progresses to secondary necrosis (red arrows) and the terminal
cytolysis is autolytic as it is carried out fromwithin by the autonomous proteolytic process under way in the apoptosing cell. This means that the complete apoptotic program
comprises a ﬁnal autolytic step (secondary necrosis). In apoptosis assisted by a scavenger cell (blue arrows), the normal progression of apoptosis is interrupted by the
incorporation of the apoptosing cell within a phagosome of the scavenger and the terminal cytolysis is by heterolysis: the apoptosing cell is dismantled by the degradative
proteolytic activity of the scavenger which induces passive necrosis of the phagocytosed apoptotic cell (efferocytosis). Cytolysis in secondary necrotic cells occurs openly and
releases potentially dangerous cellular components (OPEN AUTOLYSIS), while in assisted apoptosis cytolysis occurs in the safe niche of a phagolysosome of the scavenger that
ingests the doomed cell when it still is in the pre-necrotic phase of apoptosis, thus preventing the release of the cell contents (PROTECTED HETEROLYSIS). Although with
diverse consequences, expression of ‘‘eat-me” signals during the pre-necrotic phase occurs in the two paths of apoptosis. The upper path leading to secondary necrosis is the
rule in unicellular eukaryotes. Adapted from Fig. 1 in Ref. [104].
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apoptosis in unicellular eukaryotes in 1994 [53], all studies on cell
death modes regarded metazoans. The initial description of the
apoptotic mode of cell elimination, based on observations with
mammalian tissues [4], helped to promote the metazoan-centric
perspective that such mechanism was exclusive of multicellular
animals. When performing physiological roles in these organisms
apoptosis includes efferocytosis and is a silent and useful process
which is crucial during embryonic morphogenesis and, in adult life,
in tissue homeostasis and immune responses for the elimination of
unnecessary, unwanted or dangerous cells [54], thus perfectly ﬁt-
ting multicellularity.
More than two decades elapsed after the proposal of the term
apoptosis and before cell death with apoptotic features started to
be recognized in unicellular eukaryotes. Apoptosis was then ac-
cepted as a process not exclusive of multicellular animals but
rather as a universal mechanism of cell elimination operating
according to a basic program not only in men, mice, worms and
ﬂies but also in the simpler and more ancient forms of single-celled
eukaryotes [53,55].Indeed, cell death processes with typical apoptotic features
have progressively been reported in unicellular eukaryotes in all
major eukaryotic groups from the Opisthokonta (that includes
metazoans) to the more distant Discicristata (Table 2). When ki-
netic studies of membrane permeability were carried out in the
listed examples of apoptotic processes in unicellular eukaryotes,
secondary necrosis was found to be the outcome (Table 2), as in
the case with metazoan cells apoptosing in vitro.
It is relevant that externalization by apoptotic cells of ‘‘eat-me”
signals, namely phosphatidylserine, the most ubiquitous one in
multicellular animals [13,14], occurs not only in the case of these
eukaryotes where it fulﬁls the crucial role of providing the recog-
nition by scavengers of apoptotic cells as ‘‘unwanted self” that
must be removed [56], but also in unicellular eukaryotes where
that role is not operating. Studies with unicellular eukaryotes
where apoptosis was found to be accompanied by externalization
of phosphatidylserine regard, among others, Dictyostelium disco-
ides, Chlamydomonas reinhardtii, Plasmodium berghei, Blastocystis
hominis, Leishmania donovani, Leishmania infantum, Trypanosoma
brucei and Trypanosoma cruzi (Refs. in [57]). Importantly, yeasts,
Fig. 2. In vivo secondary necrosis in a vertebrate. Transmission electron microscopy of peritoneal sea bass macrophages following the i.p. inoculation of the bacterial ﬁsh
pathogen Photobacterium damselae subsp. piscicida that secretes the exotoxin AIP56 with selective apoptogenic activity towards macrophages and neutrophils [123].
Bar = 0.75 lm. Technical details in Ref. [124]. (A) A normal macrophage. (B) A macrophage under apoptosis, showing cell shrinkage, dense cytosol, intense chromatin
condensation and a continuous cytoplasmic membrane. (C) A macrophage under terminal secondary necrosis identiﬁed by the co-existence of an apoptotic marker
(hypercondensed nuclear fragment) and necrotic features (clear cytosol and rupture of the cytoplasmic membrane with extensive cell disintegration).
Table 2
Examples of eukaryotic unicellular organisms where secondary necrosis was found as the natural outcome of apoptosis
Eukaryotic groupa Organism References
Apoptotic markers Occurrence of secondary necrosis
Opisthokonts Yeasts [125] [126]
Amoebozoa Dictyostelium discoideum [127] [128]
Plants Dunaliella viridis [57] [129]
Chlamydomonas reinhardtii [57] [67]
Alveolates Plasmodium berghei [57] [130]
Heterokonts Blastocystis hominis [131] [132]
Discicristates Leishmania donovani [133] [134]
Trypanosoma brucei [135] [136]
Trypanosoma cruzi [55] [137]
a The listed groups represent six of the eight eukaryotic groups considered by Baldauf [58]. It is of note that the Opisthokonts comprise fungi (including yeasts) and
multicellular animals.
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ize phosphatidylserine during apoptosis. This was found in Candida
albicans [59,60], Schizosaccharomyces pombe [61] and Saccharomy-
ces cerevisiae [62–65]. Externalization of phosphatidylserine also
has been found in apoptotic cells of higher plants where phagocy-
tosis by scavengers cannot operate [66,67]. Moreover, mammalian
phagocytes ingest viable, non-apoptotic cells expressing external-
ized phosphatidylserine [68–70], as well as necrotic cells express-
ing that ‘‘eat-me” signal [71]. Additionally, it has been shown that
C. elegans uses the same set of engulfment genes for removal of
both apoptotic and necrotic cells [72]. Thus, the recognition andingestion by phagocytes of cells through the detection of phospha-
tidylserine is not a mechanism speciﬁc of clearance of apoptotic
cells.
The above observations suggest that externalization of mole-
cules that are recognized by phagocytes as ‘‘eat-me” signals ap-
peared as a by-product of the endogenous degradative process of
apoptotic cell death before the emergence of multicellularity and
without the theological purpose of promoting the quick and safe
clearance of apoptotic cells by scavenger phagocytes before pro-
gression to secondary necrosis. This feature of apoptosis would
have been maintained during evolution and, in multicellular
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of ‘‘eat-me” signals as a signal for phagocytosis and elimination.
Clearance by scavengers of apoptotic cells is a crucial feature of
physiological apoptosis in multicellular animals and has been ob-
served at all levels of multicellularity, including in the simplest
forms like hydra [73]. Accordingly, those organisms reﬁned the
process of removal of apoptotic corpses through the use, as men-
tioned above, of several redundant ‘‘eat-me” signals besides phos-
phatidylserine as well as of bridging molecules and of ‘‘ﬁnd-me”
signals, together with the elimination of ‘‘don’t eat-me” signals,
an indication of the extreme importance of efferocytosis in the
context of animal multicellularity.
Thus, the complete apoptotic process, with its secondary necro-
tic outcome, is an ancient molecular program common to uni- and
multicellular eukaryotes. As in isolated metazoan cells, the apopto-
tic death of a unicellular eukaryote, once triggered, is self-sufﬁcient
and leads to self-elimination by secondary necrosis.3. In multicellular animals avoidance of secondary necrosis
through efferocytosis is advantageous
When part of a multicellular animal, a cell that disintegrates by
secondary necrosis during in vitro solitary apoptosis will respond
to an apoptotic stimulus again by activating its endogenous apop-
totic program. However, the outcome will typically be different
from that occurring when the cell is isolated because now the
apoptosing cell is part of the social context of the multicellular
organization [74] and the early expression of ‘‘eat-me” signals at
its surface promotes the removal by phagocytes of the doomed cell
before progression to secondary necrosis. The primary function of
apoptosis in multicellular animals is ‘‘controlled cell deletion” [4]
and this is achievable through secondary necrosis. However, elim-
ination of apoptotic cells by heterolytic efferocytosis instead of
autolytic secondary necrosis has crucial advantages to multicellu-
lar animals. These advantages include increased speed of cell elim-
ination and more extensive degradation of the apoptotic cell
components [8,10,11] and energetically proﬁtable reutilization of
phagocytosed and digested components of apoptotic cells allowing
for the recycling of molecules [4,75]. Moreover, and most impor-
tantly, elimination by efferocytosis occurs while the apoptosing
cell still is enveloped by a plasma membrane with retained integ-
rity, and cell disintegration, including permeabilization of the
membrane, takes place in the safe recess of the phagolysosome
of scavenger cells (protected heterolysis; Fig. 1). This prevents sec-
ondary necrotic autolysis which occurs openly (open autolysis;
Fig. 1) and thus is potentially pathogenetic as it releases partially
degraded pro-inﬂammatory and immunogenic cell components
as will be discussed in the next section.
Therefore, the acquisition of the ability to recognize and remove
pre-necrotic apoptosing cells as structures that must be cleared be-
fore the completion of the apoptotic program represented a crucial
step forward for multicellular animals and conferred to physiolog-
ical apoptosis in these organisms a particular characteristic depen-
dent on efferocytosis.4. In multicellular animals secondary necrosis may have
relevant medical implications
Although, as mentioned, secondary necrosis in multicellular
animals can occur in vivo in particular physiological situations,
typically it represents an event with pathological implications be-
cause of the frequently deleterious effects of exposition and release
of cell constituents [7,28,43,76].
One mechanism for the genesis of pathogenic consequences of
extensive or persistent apoptotic secondary necrosis is the leakageof cytotoxic, pro-inﬂammatory and immunogenic molecules by the
autolysing cells. These molecules include damage-associated
molecular patterns (DAMPs) [77]. The impact of the release of
these molecules on the inﬂammatory and immune responses de-
pends on the context in which cell death occurs [78], and it may
be beneﬁcial as will be discussed below in regards to immunogenic
cell death in tumors. However, necrosis-associated release of
DAMPs often has pathological pro-inﬂammatory and immunogenic
consequences [28,78,79], contributing to the pathology frequently
associated with extensive or persistent secondary necrosis. Release
of lysosomal proteolytic enzymes and the oxidative burst occurring
during secondary necrosis may participate in the generation of
DAMPs by modifying original cell components which are later re-
leased due to the eventual rupture of the plasma membrane [27].
Among pro-inﬂammatory and immunogenic DAMPS released by
secondary necrotic cells are proteases, nucleosomes consisting of
double-stranded DNA and histones, S100 calgranulin proteins, high
mobility group box-1 (HMGB-1) protein, proteolytically processed
autoantigens, and urate crystals [26,28,78,80,81]. Nucleosomes
produced during the apoptotic death process by internucleosomal
DNA degradation may persist until secondary necrotic cell disinte-
gration and be released [82] participating in the genesis of autoim-
mune disorders [81,83]. Nucleosomes are present in increased
amounts in the circulation of patients with systemic lupus erythe-
matosus (SLE) [84].
Secondary necrotic cells can be phagocytosed by scavengers
in vivo following molecular mechanisms that have recently been
reviewed [85]. That phagocytosis is promoted by ‘‘eat-me” signals
including ACAMPs exposed during the apoptotic pre-necrotic
phase [12] and by modiﬁed cell components altered by proteolysis
and oxidative events occurring in the necrotic phase and made
accessible by plasma membrane rupture [27,85]. Therefore, the
process of clearance of early (pre-necrotic) and late (secondary ne-
crotic) apoptotic cells are not identical and usually have diverse
consequences in terms of inﬂammatory and immunogenic re-
sponses. While typically the clearance of early apoptotic cells by
scavenger phagocytes is anti-inﬂammatory [31,86], phagocytosis
of secondary necrotic cells often is pro-inﬂammatory and immuno-
genic and thus may represent another mechanism for the genesis
of pathogenic consequences of secondary necrosis [13,85].
In vivo neutrophil lysis due to secondary necrosis is particularly
pathogenic [43,76] as these phagocytes are recruited in very high
numbers to inﬂammatory sites [6] and are extraordinarily rich in
cytotoxic, tissue damaging molecules [87,88]. One highly cytotoxic
phagocyte molecule released by secondary necrotic cells is neutro-
phil elastase [89,90]. Extracellular active neutrophil elastase was
found in several infections where neutrophil secondary necrosis
is implicated as a pathogenicity mechanism [48,49,91].
Secondary necrosis may therefore produce acute and chronic
pathology, thus being a mechanism for apoptosis turning patho-
genic. Secondary necrosis has recently been implicated in an
increasing number of human clinically important situations of
acute and chronic inﬂammation with apoptotic cytopathology
including many autoimmune disorders [92,93], ischemia [94], ath-
erosclerosis [95,96], chronic obstructive pulmonary disease (COPD)
[97–99], lung inﬂammation associated with oxidative stress
including in smokers [100], cystic ﬁbrosis [49,101], asthma [102],
bronchiectasis [103], and infection [104].
On the other hand, secondary necrosis affecting tumor cells has
recently gained an additional relevance due to its recognition as a
process with likely beneﬁcial implications in anticancer therapies
by facilitating the activation of the immune system and conse-
quently the clearance of tumor cells. Anticancer chemotherapy
[105] and radiotherapy [106] are largely mediated by apoptosis.
It has been reported that, after treatment with some chemothera-
peutic agents or ionizing irradiation, tumor cells may become
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(reviewed in [107]). Several observations have been accumulated
suggesting that such immunogenicity is associated to the progres-
sion to secondary necrosis of therapy-induced apoptotic tumor cell
death and to the release by secondary necrotic tumor cells of the
DAMPmolecule HMGB-1: (i) tumor cells treated in vitro with some
apoptogenic chemotherapeutic agents or radiotherapy release
HMGB-1 protein, and secondary necrosis was suggested to be the
mechanism for that release [108]. (ii) As discussed elsewhere
[109,110], clearance of apoptotic cells may be insufﬁcient during
therapy-induced apoptotic tumor cell death in vivo, resulting in
the accumulation of secondary necrotic cells. (iii) It has been found
that secondary necrotic tumor cells stimulate DCs [111–113], and
thus are immunogenic [110]. The presentation of tumor antigens
by mature DC leads to CD4+ and CD8+ T cell activation. HMGB-1
released by secondary necrotic tumor cells is recognized by DCs
which prime CD4+ and CD8+ T cells and thereby trigger immuno-
genic T helper 1 cell and cytotoxic T lymphocyte responses, respec-
tively [80,108,114]. Although less efﬁciently than macrophages
[115] DCs may engulf apoptotic cells, mainly when extensive apop-
tosis overwhelms the macrophage availability [116] or in territo-
ries where DCs outnumber macrophages [117].
5. Identiﬁcation of cells under secondary necrosis
Necrotic cells seen in cultures or in vivo may represent cells that
are being affected by apoptotic secondary necrosis or, instead, by
primary necrosis, and there is the possibility of a misinterpretation
of the cell elimination process involved in the genesis of the necro-
tic cells. There are many examples in the literature of studies
describing inducers of cell death as triggers of primary necrosis
based on experiments where the death process behind that necro-
sis is apoptotic. This misinterpretation occurs when the lack of
adequate kinetic assessments prevents the observation of the
pre-necrotic phase of apoptosis and only reveals a necrotic out-
come wrongly labeled as primary necrosis. And this is not an issue
of academic interest; rather, the correct classiﬁcation of cell death
into speciﬁc modalities may be extremely important including in
medical situations. Thus, methods for the correct identiﬁcation of
cells under secondary necrosis are important and have been de-
scribed in detail elsewhere [35,104,118]. As secondary necrosis af-
fects cells that have gone through particular apoptotic alterations,
secondary necrotic cells exhibit a speciﬁc morphotype (Table 1)
that associates apoptotic features, like hypercondensed chromatin
(pyknosis) and nuclear fragmentation (karyorrhexis), and necrotic
features, like rupture of the cytoplasmic membrane (Fig. 2). For the
same reason, cells under secondary necrosis, contrary to primary
necrotic cells, release activated caspase-3 [118,119] which can be
detected in vivo [48,83,120].
6. Concluding remarks
Apoptosis is a genetically regulated form of active cell death
that uses machinery intrinsic to the cell and represents an ancient
molecular mechanism common to all levels of eukaryotic organiza-
tion. The apoptotic program comprises two events which provide
two alternative courses with diverse mechanisms of cell elimina-
tion: (i) early exposure of surface signals that, in multicellular ani-
mals, allow scavenger phagocytes to recognize apoptotic cells as
unwanted self. These cells are removed before the completion of
the apoptotic program and are dismantled through heterolysis by
the scavenger, meaning that this course of apoptosis includes the
burial of the dead cell (efferocytosis) as the ﬁnal part of the pro-
cess. This is the outcome that makes physiological apoptosis a si-
lent cell elimination process in multicellular animals, the one
initially described when the term apoptosis was introduced [4],and the one considered in the recommended deﬁnition of in vivo
apoptosis [3,19,121]. (ii) Secondary necrosis which, in the absence
of scavengers, is activated at the end of the full apoptotic program
and leads to the autolytic disintegration of the doomed cell [20].
As efferocytosis does not operate with unicellular eukaryotes,
secondary necrosis is the natural outcome of apoptosis in these
organisms. For the same reason, secondary necrosis is the rule
when in vitro cultured non-phagocytic cells from multicellular
organisms undergo apoptosis. However, importantly, secondary
necrosis also occurs in vivo in multicellular animals in some phys-
iological and, more frequently, pathological situations when func-
tional scavenger cells are not available and the apoptotic program
fully unrolls. Under a broad biological perspective encompassing
uni- andmulticellular eukaryotes, secondary necrosis is the natural
conclusion of the complete apoptotic program, exhibits particular
molecular and morphological features and represents a speciﬁc
mode of cell elimination. The typical course of physiological apop-
tosis in multicellular animals, as originally described by Kerr and
colleagues [4] and predominantly considered in the literature,
therefore involves a deviation from the apoptotic program pre-
venting its completion. The deﬁnition of apoptosis as a process
which terminates with the removal and disintegration of the apop-
tosing cell by a scavenger, as is predominant in the literature, rep-
resents a metazoan-centric perspective and, even speciﬁcally
considering metazoans, is restrictive. Contrasting with the abun-
dance of studies on apoptosis and on the clearance of apoptotic
cells by scavengers, the study of, and reference to secondary
necrosis has been largely neglected, reﬂecting that predominant
deﬁnition. For example, recent and important texts with recom-
mendations on the use of cell death-related terminology proposed
by the NCCD [3,19] and on the use and interpretation of assays for
monitoring cell death in higher eukaryotes [122] do not mention
secondary necrosis. Further research on secondary necrosis will
certainly reveal new instances where this mode of cell elimination
has a pathogenetic role or new possibilities for the improvement of
therapeutic interventions.
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